Department of Health and Human Services January 17, 2008 – Federal Register Recent Federal Regulation Documents
Results 1 - 13 of 13
Intramammary Dosage Forms; Cephapirin Sodium
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of supplemental new animal drug applications (NADAs) filed by Fort Dodge Animal Health, Division of Wyeth. The supplemental NADAs provide for revisions to the labeling of two cephapirin sodium products administered by intramammary infusion to lactating cows for the treatment of mastitis.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.